Creating elegant software that guides successful drug discovery

Cambridge, UK
Joined September 2009
Replying to @Optibrium
@Optibrium, known for their software solutions for small molecule design, optimisation, and data analysis, is a Gold Sponsor at #DiscoveryUS24! ✨ Don't miss the chance to connect with their team and learn about their cutting-edge technologies. Agenda: hubs.la/Q02D__7s0
2
92
Winner of #Software Company of the Year sponsored by @mantlespace at #SciTechAwards is @Optibrium - which creates software that aids successful drug discovery. Congratulations!
1
1
390
The all-cis-tetrafluorocyclohexane, an interesting polarized Janus face ring isostere of the morpholine ring has been recently entered into BIOSTER database. @Optibrium
1
1
163
🔎Michael Parker, Principal AI Scientist at @Optibrium, discusses generative #chemistry and other exciting #AI applications in #smallmolecule drug discovery. 📜 bit.ly/47XXwrQ
1
107
Explore how @Optibrium's sophisticated software solutions are transforming small molecule design, optimisation, and data analysis at #DiscoveryEU24 🌟 ▶️ Learn more: hubs.la/Q02sFR-d0 #OGDiscovery #DiscoveryEU24 #MoleculeDesign #DataAnalysis
1
62
📚 #ReadoftheWeek Mario Öeren, Principal Scientist at @Optibrium, explores the role of quantum mechanics and machine learning in #drugdevelopment. 🔬 👉 bit.ly/4ao37tw
1
97
Our Editor, @SJC_Sutton, shares details from our article with Michael Parker, Principal #AI #Scientist at @Optibrium. The article discusses generative chemistry and other exciting applications of #artificialintelligence in #smallmolecule #drugdiscovery. bit.ly/47XXwrQ
1
122
🔎Michael Parker, Principal AI Scientist at @Optibrium, discusses generative #chemistry and other exciting #AI applications in #smallmolecule drug discovery. 📜 bit.ly/47XXwrQ
1
1
108
. @Optibrium launches Semeta™, a #metabolism prediction platform tailored specifically for #DMPK scientists. Fundamental to improving a #drug’s chance of success, Semeta allows the accurate prediction of Phase I & II metabolism in early #drugdiscovery ➡ rb.gy/e32txl
1
1
70
. @Optibrium has launched Idea Tracker to enable collaborative design in its latest version of StarDrop. With Idea Tracker, #medicinalchemists can now easily trace #moleculardesign & optimisation decisions through every step of the #drugdiscovery process: rb.gy/gsy1oj
1
64
.@Optibrium has announced the publication of its peer-reviewed paper in Xenobiotica, describing a new method to determine most likely routes of metabolism of a drug candidate and metabolites to be observed experimentally: rb.gy/p0mgeq #MachineLearning #DrugDesign
1
63
BIOSTER database annual update has just been submitted to @Optibrium for incorporation into StarDrop. It now contains >37k literature reported analog pairs (bioisosteres, linker replacements, conformational constraints, prodrugs etc.) for MedChem & AgChem structure optimisations.
1
1
118
Discover the Metabolism module—your key to predicting, optimizing, and ensuring success in Phase I and II metabolism. Link :- optibrium.com/videos/metabol… #CADD #MedChem #CompChem #DrugDiscovery #Pharma #Biotech #CRO @Optibrium @ZastraIndia
1
1
2
76
Discover the advancements in StarDrop 7.5, featuring the new Metabolism module, high-performance virtual screening with Surflex click the link to watch. Link :-optibrium.com/events/webinar… #CADD #MedChem #CompChem #DrugDiscovery #Pharma #Biotech #CRO @Optibrium @ZastraIndia
1
1
2
91
🥼@Optibrium introduces a cloud-based version of StarDrop, its #drugdiscovery platform. StarDrop in the cloud retains all the interactivity of the desktop version, with the added benefits of flexible access, hassle-free deployment and easy maintenance: rb.gy/wkbod
1
1
2
101
Where is the #drugdiscovery expertise happening in the UK? In its latest issue, @DDWJournal talks with experts from across the country, discussing exciting #research, #technology and the #lifescience hubs that help make it possible. Read it here: rb.gy/o8bkl
1
1
94
Optibrium retweeted
.@Optibrium launches StarDrop 7.5: an AI-driven tool combining quantum mechanics & ML for advanced drug metabolism predictions. Covering 80% of Phase I & 60% of Phase II metabolism, it aims to revolutionize early-stage drug design. cambridgenetwork.co.uk/news/…
2
3
137
Cambridge-based @Optibrium, which develops software and AI solutions for drug discovery, has acquired California company @biopharmics LLC to expand its 3D drug design and modelling offering. No sums are being disclosed for the deal. tinyurl.com/ybuvr8r2
2
2
252
Announced today, @Optibrium acquires @biopharmics, expanding its 3D ligand- and structure-based #drugdesign and modelling offering, and welcomes computational #chemistry and #biology experts Ajay Jain and Ann Cleves to its team: rb.gy/458f9 #DrugDiscovery #Software
2
4
174